Mr. Ruppel leads Coridea’s preclinical device development. He has a principal technical role in bringing device designs from ideas to clinical devices.
Since joining Coridea in 2017, Mr. Ruppel has lead engineering efforts for multiple devices addressing unmet clinical needs, as well as supporting several Coridea portfolio companies with device and model development for preclinical studies.
Mr. Ruppel earned a Master’s of Science in Engineering in Bioengineering from the Johns Hopkins Center for Bioengineering, Innovation, and Design. His research there included leading engineering development on a novel therapy for the treatment of pulmonary hypertension, and a device for the prevention of pneumothorax during percutaneous lung biopsy. He earned his Bachelor’s degree in Biomedical Engineering from the University of Rochester.